Piscataqua Savings Bank’s Insight Molecular Diagnostics IMDX Stock Holding History

Piscataqua Savings Bank’s Portfolio IMDX Stock Details IMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147	Hold	25	–	–	﹤0.01%	406
2026 Q1	$81	Hold	25	–	–	﹤0.01%	413
2025 Q4	$187	Hold	25	–	–	﹤0.01%	400
2025 Q3	$82	Hold	25	–	–	﹤0.01%	349
2025 Q2	$75	Hold	25	–	–	﹤0.01%	367
2025 Q1	$76	Hold	25	–	–	﹤0.01%	336
2024 Q4	$59	Hold	25	–	–	﹤0.01%	345
2024 Q3	$71	Hold	25	–	–	﹤0.01%	345
2024 Q2	$73	Hold	25	–	–	﹤0.01%	347
2024 Q1	$73	Hold	25	–	–	﹤0.01%	402
2023 Q4	$62	Hold	25	–	–	﹤0.01%	349
2023 Q3	$77	Hold	25	–	–	﹤0.01%	353
2023 Q2	$115	Hold	25	–	–	﹤0.01%	346
2023 Q1	$175	Hold	25	–	–	﹤0.01%	352
2022 Q4	$160	Hold	25	–	–	﹤0.01%	342
2022 Q3	$0	Hold	25	–	–	﹤0.01%	343
2022 Q2	$0	Hold	25	–	–	﹤0.01%	353
2022 Q1	$1K	Hold	25	–	–	﹤0.01%	346
2021 Q4	$1K	Hold	25	–	–	﹤0.01%	333
2021 Q3	$2K	Hold	25	–	–	﹤0.01%	325
2021 Q2	$3K	Hold	25	–	–	﹤0.01%	310
2021 Q1	$3K	Buy	+25	New	+$2.37K	﹤0.01%	313

Other funds holding IMDX

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

FOR

Family Office Research Bethesda, Maryland $267M AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Piscataqua Savings Bank's IMDX Position: Q2 2026 in Review

Piscataqua Savings Bank held its Insight Molecular Diagnostics (IMDX) position steady in Q2 2026 at 25 shares worth $147. The position accounts for ﹤0.01% of the portfolio, ranked #406.

Piscataqua Savings Bank first reported a position in IMDX in Q1 2021 and has held it in 22 quarters since. The position peaked at $3K in Q2 2021. 40 funds tracked by Wall St. Rank hold IMDX as of Q2 2026.

Piscataqua Savings Bank held 25 shares of Insight Molecular Diagnostics worth $147 as of Q2 2026.
Piscataqua Savings Bank left its Insight Molecular Diagnostics share count unchanged in Q2 2026.
Insight Molecular Diagnostics made up ﹤0.01% of Piscataqua Savings Bank's portfolio in Q2 2026, its #406 holding.
Piscataqua Savings Bank first reported a position in Insight Molecular Diagnostics in Q1 2021 and has held it in 22 quarters since.
Piscataqua Savings Bank's Insight Molecular Diagnostics position peaked at $3K in Q2 2021.
40 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2026.

Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.